# Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo

> **NCT04549376** · PHASE2 · COMPLETED · sponsor: **DR. MALA KHAN** · enrollment: 200 (actual)

## Conditions studied

- COVID19

## Interventions

- **DRUG:** Povidone-Iodine 0.4% NI
- **DRUG:** Povidone-Iodine 0.5% NI
- **DRUG:** Povidone-Iodine 0.6% NI
- **DRUG:** Povidone-Iodine 0.5% NS
- **DRUG:** Povidone-Iodine 0.6% NS
- **OTHER:** Placebo comparator: DW-NI
- **OTHER:** Placebo comparator: DW-NS

## Key facts

- **NCT ID:** NCT04549376
- **Lead sponsor:** DR. MALA KHAN
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2020-10-20
- **Final completion:** 2020-10-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04549376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04549376, "Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04549376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*